The Amazon, Berkshire Hathaway, JP Morgan Chase Healthcare Joint Venture Now Named Haven
Biospace | March 07, 2019
In January 2018, Berkshire Hathaway’s Warren Buffett, Amazon’s Jeff Bezos, and JP Morgan Chase’s Jamie Dimon announced they were creating a joint venture to slash healthcare costs and improve services. For more than a year, it had no name other than “ABC,” the first letters of each company’s name. Now, more than a year later, the endeavor has an official name, Haven. The three moguls formed the company with the idea of improving healthcare access and lowering costs for their combined companies’ 1.2 million employees and families in the U.S. How that’s going to be accomplished, and whether what it does will be applicable to broader U.S. healthcare, remains unknown. In June 2018, Atul Gawande came on as the chief executive officer of the joint venture. Gawande practices general and endocrine surgery at Brigham and Women’s Hospital and is a professor at the Harvard T.H. ChFan School of Public Health and Harvard Medical School. He is also founding executive director of Ariadne Labs, a health systems innovation center.